Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

pexels edward jenner 4033304

Gene-editing using the groundbreaking CRISPR technology is about to be put to the test in the first-ever clinical trial of the treatment in humans. CRISPR is a protein in bacteria that can be used to manipulate genetic material to, according to Jennifer Doudna, who won last year’s Nobel Prize in Chemistry for the development of CRISPR technology, “alter[] DNA sequences in any cell in a precise fashion, in a programmable fashion.” This remarkable technology has the potential to eliminate all genetic disorders and is already delivering results that scientists say were unimaginable just a few years ago.

As is observed in the Netflix documentary series “Unnatural Selection,” we are now “doing science fiction science,” and have been thrust more quickly than we expected into a new world in which our genetic blueprints can be tweaked and optimized. Many bioethicists see such interventions as a potentially dangerous affront to the natural order, opening a Pandora’s Box of potentially disastrous outcomes we can’t begin to predict.

Yet, it is not at all obvious what the term “natural” means or ought to mean, particularly within the context of a human history defined by technological interventions that necessarily restructure natural reality. We may wonder, for example, whether the domestication of grains was natural, whether the use of vaccines to conquer smallpox and polio was natural, whether turning wolves into dogs tens of thousands of years ago was natural, whether using our knowledge of genetics to safely increase the quality and quantity of our crops was natural, whether the very practice of medicine as we know it today is natural, etc.

Read the rest of this article at The Hill

David D'Amato

David S. D’Amato is an attorney and adjunct law professor whose writing has appeared at the Institute of Economic Affairs, the Future of Freedom Foundation, the Centre for Policy Studies, the Ludwig von Mises Institute, Liberty Fund’s Online Library of Law and Liberty, the Foundation for Economic Education, and in major newspapers around the world. D’Amato is on the Board of Policy Advisors for the Heartland Institute and he is the Benjamin Tucker Research Fellow at the Molinari Institute’s Center for a Stateless Society. He earned a JD from New England School of Law and an LLM in Global Law and Technology from Suffolk University Law School.

View all posts

Our Books

Recent Articles

Recent

TGIF: Notes on Anarcho-Capitalism

TGIF: Notes on Anarcho-Capitalism

I'm pretty sure I won't be around long enough to see anarcho-capitalism—or what I call market-ordered anarchism—prevail in the United States. I'm just as sure that I won't see government strictly limited to protecting individual rights and never violating them (if...

read more
WMDs for a MIC in Need

WMDs for a MIC in Need

In the closing days of 2025, the White House turned an opioid crisis into a national security drama. Standing in the Oval Office during a Mexican Border Defense Medal ceremony on December 15, President Donald Trump declared that he would sign an executive order to...

read more
Smashing the ‘Roosevelt Myth’

Smashing the ‘Roosevelt Myth’

David T. Beito’s FDR: A New Political Life offers a bracing, deeply researched, and welcome reassessment of Franklin Delano Roosevelt, one that decisively breaks with the hagiographic tradition that has dominated twentieth century American historiography. The book’s...

read more

Pin It on Pinterest

Share This